Fact Sheet: President Donald J. Trump Announces First Deal to Bring Most-Favored-Nation Pricing to American Patients
Fact sheetPublished 25/09/30Open the original
Summary
President Trump announces the first most-favored-nation pricing agreement, with Pfizer: every state Medicaid program gets MFN prices on Pfizer products, new medicines launch at MFN prices, and direct-purchase discounts include 80% on Eucrisa and 40% on Xeljanz.
By industry
- Healthcare & Drug Pricing1 trading day+2.1%p15 stocks5 trading days+3.8%p15 stocks20 trading days+3.3%p15 stocks
“announced the first agreement with a major pharmaceutical company, Pfizer”
Day by day after the announcement
| Day | Healthcare & Drug Pricing stocks | S&P 500 |
|---|---|---|
| 25/09/29 | 0.0% | 0.0% |
| 25/09/30 | +2.3% | +0.2% |
| 25/10/01 | +5.4% | +0.7% |
| 25/10/02 | +5.1% | +0.9% |
| 25/10/03 | +5.7% | +0.9% |
| 25/10/06 | +5.0% | +1.3% |
| 25/10/07 | +5.7% | +0.9% |
| 25/10/08 | +5.8% | +1.5% |
| 25/10/09 | +5.8% | +1.1% |
| 25/10/10 | +4.8% | −2.2% |
| 25/10/13 | +4.6% | −0.1% |
| 25/10/14 | +4.8% | −0.2% |
| 25/10/15 | +5.0% | +0.3% |
| 25/10/16 | +4.0% | −0.5% |
| 25/10/17 | +5.5% | +0.2% |
| 25/10/20 | +6.5% | +1.3% |
| 25/10/21 | +6.7% | +1.2% |
| 25/10/22 | +6.4% | +0.7% |
| 25/10/23 | +6.0% | +1.3% |
| 25/10/24 | +6.3% | +2.1% |
| 25/10/27 | +6.7% | +3.4% |
Stocks it names
Korean stocks in these industries
- Samsung Biologics 207940
- Celltrion 068270
- SK Biopharmaceuticals 326030
Trades in these industries around the announcement
Members' and insiders' trades in the industries' stocks, 30 days before to 30 days after.
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$83M
101,112 sh
$83M
Filed 25/10/03
Traded 25/10/02
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$69.1M
90,501 sh
$69.1M
Filed 25/10/01
Traded 25/09/30
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$54.2M
63,849 sh
$54.2M
Filed 25/10/07
Traded 25/10/06
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$30.7M
36,114 sh
$30.7M
Filed 25/10/09
Traded 25/10/08
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$30.4M
39,863 sh
$30.4M
Filed 25/09/19
Traded 25/09/18
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$26.1M
31,102 sh
$26.1M
Filed 25/10/06
Traded 25/10/03
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$23.8M
28,063 sh
$23.8M
Filed 25/10/07
Traded 25/10/06
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$22.7M
26,795 sh
$22.7M
Filed 25/10/08
Traded 25/10/07
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$21.5M
25,296 sh
$21.5M
Filed 25/10/09
Traded 25/10/08
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$20.6M
24,495 sh
$20.6M
Filed 25/10/06
Traded 25/10/03
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$20.4M
26,647 sh
$20.4M
Filed 25/09/19
Traded 25/09/18
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$19.5M
22,960 sh
$19.5M
Filed 25/10/07
Traded 25/10/06
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$19.2M
23,151 sh
$19.2M
Filed 25/10/02
Traded 25/10/01
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$19.1M
22,843 sh
$19.1M
Filed 25/10/06
Traded 25/10/03
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$17.6M
23,067 sh
$17.6M
Filed 25/09/19
Traded 25/09/18
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$17.5M
22,965 sh
$17.5M
Filed 25/09/22
Traded 25/09/19
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$15.7M
18,986 sh
$15.7M
Filed 25/10/02
Traded 25/10/01
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$15.4M
18,710 sh
$15.4M
Filed 25/10/02
Traded 25/10/01
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$15.4M
18,132 sh
$15.4M
Filed 25/10/09
Traded 25/10/08
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$15M
18,465 sh
$15M
Filed 25/10/02
Traded 25/10/01